Dermatology
Acanthosis Nigricans
Acanthosis nigricans should prompt etiologic triage rather than cosmetic treatment alone: most cases reflect obesity-associated insulin resistance, but abrupt generalized, mucosal, or nonobese presentations require evaluation for medication, endocrine, autoimmune, and malignant drivers.
First decision
Classify the presentation before ordering tests
The distribution, tempo, body habitus, and extracutaneous findings determine the initial workup.
Confirm the clinical phenotype: symmetric, hyperpigmented, velvety plaques with poorly defined borders, usually in intertriginous areas, support acanthosis nigricans. Skin tags commonly coexist around affected sites in insulin-resistant phenotypes. PubMed+1PubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS
The common branch is obesity-associated insulin resistance. In children, adolescents, and adults with overweight or central adiposity, neck and axillary involvement should redirect the encounter toward dysglycemia, dyslipidemia, hypertension, and fatty-liver risk rather than biopsy or lesion-directed therapy. Acanthosis nigricans identifies higher metabolic risk, but obesity is more predictive of insulin resistance than the skin finding alone. BMJ+2BMJType 2 diabetes in children - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedAn approach to acanthosis nigricans - PMCPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Escalate beyond routine metabolic assessment when lesions are abrupt, rapidly progressive, extensive or generalized, involve oral or other mucosa, or arise in a nonobese patient without an evident insulin-resistant state. Malignant lesions can be clinically indistinguishable from benign lesions; gastrointestinal adenocarcinoma, particularly gastric carcinoma, is the classic association. ScienceDirect+2ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS
Ask about tempo: longstanding lesions tracking with weight gain favor obesity-associated disease; rapid new progression increases concern for a systemic driver. ScienceDirect+1ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed
Review medications and supplements because acanthosis nigricans is associated with drugs as well as insulin resistance, endocrine disorders, chromosomal abnormalities, and neoplasia. Wiley+1WileyPosters - 2017 - Australasian Journal of DermatologyPubMedAcanthosis Nigricans: An Updated Review - PubMed
Ask about menstrual irregularity, hirsutism, acne, or virilization; acanthosis nigricans can be a cutaneous marker of polycystic ovary syndrome and other hyperandrogenic states. Wiley+2WileyISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ...ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Ask about symptomatic hypo- or hyperglycemia and autoimmune disease when severe insulin resistance is disproportionate to adiposity; type B insulin resistance may present with either hyperglycemia or hypoglycemia. Wiley+1WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : Medicine
Common pathway
Evaluate obesity-associated acanthosis nigricans as a metabolic risk marker
The purpose of testing is to identify actionable dysglycemia and cardiometabolic comorbidity.
At the initial visit, record height, weight, BMI, waist or hip circumference when useful for adiposity assessment, and blood pressure. Examine for skin tags, hirsutism, goiter, abdominal tenderness or hepatomegaly, and broad pink striae when the history suggests endocrine disease. WHO+1WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Obtain fasting plasma glucose and hemoglobin A1c to detect dysglycemia, and obtain a fasting lipid profile to identify atherogenic dyslipidemia. Add ALT when obesity-associated metabolic dysfunction or hepatic steatosis is a concern; overweight and obese children with acanthosis nigricans have demonstrated higher fasting glycemia, insulin, HOMA index, triglyceride-related metabolic abnormalities, and aminotransferase levels than peers without lesions. WHO+1WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Do not use acanthosis nigricans as a stand-alone proxy for insulin resistance or type 2 diabetes. In obese children, the presence of lesions is associated with insulin resistance, but obesity itself remains the more important determinant; a normal glucose result does not negate the need to address excess adiposity and longitudinal metabolic risk. PubMed+1PubMedAcanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children - PubMedPubMedAn approach to acanthosis nigricans - PMC
For youth with obesity plus acanthosis nigricans, recognize the lesion as a sign of insulin resistance that strengthens concern for type 2 diabetes risk. BMJ+1BMJType 2 diabetes in children - Symptoms, diagnosis and treatment | BMJ Best Practice USWileyISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ...
When fasting glucose and hemoglobin A1c do not explain the clinical phenotype but concern for glucose intolerance remains high, consider an oral glucose tolerance test; OGTT has been used to characterize glucose tolerance and insulin resistance in obese children with acanthosis nigricans. PubMed+1PubMedAcanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children - PubMedWHO[PDF] PHC ENG GUIDE 200 - Extranet Systems
In patients with obesity-associated disease, use the laboratory results to manage dysglycemia, hypertension, dyslipidemia, and suspected fatty liver rather than treating pigment alone. WHO+1WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Escalation
Recognize endocrine, autoimmune, and malignancy-associated patterns
Rare causes matter when phenotype severity or clinical context is discordant with ordinary obesity-associated disease.
Consider endocrine-associated acanthosis nigricans when there are syndrome-specific findings. Hyperandrogenic and hypogonadal states, Cushing disease, Addison disease, hypothyroidism, and diabetes-related insulin resistance have been reported associations. In a patient with corresponding symptoms or examination findings, test for the suspected disorder rather than applying a broad endocrine panel. ScienceDirect+1ScienceDirectAcanthosis nigricans, hypothyroidism, and insulin resistance - ScienceDirectScienceDirectAcanthosis Nigricans - an overview | ScienceDirect Topics
Type B insulin resistance is an autoimmune syndrome caused by insulin-receptor autoantibodies and can produce severe insulin resistance with hyperglycemia or, less often, hypoglycemia. During a spontaneous hypoglycemic event, obtain glucose with insulin, proinsulin, and C-peptide; confirmation requires insulin-receptor autoantibody detection. The coexistence of acanthosis nigricans, extreme hyperinsulinemic biochemistry, autoimmune features, and hyperandrogenism or female virilization should prompt urgent endocrinology involvement. Wiley+1WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : Medicine
For suspected malignant acanthosis nigricans, use history and examination to direct cancer testing rather than assuming that lesion morphology distinguishes malignant from metabolic disease. Gastric carcinoma is the most common reported tumor association, and adenocarcinomas of the gastrointestinal tract, ovary, lung, and breast have been described. Mucosal involvement may include the oral cavity, nasal or laryngeal mucosa, or esophagus. ScienceDirect+1ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS
A nonobese patient with new acanthosis nigricans and no evident insulin-resistant phenotype needs malignancy assessment and medication review. ScienceDirect+1ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed
Mucosal lesions or widespread papillomatous disease increase the need to investigate a paraneoplastic pattern, while recognizing that mucosal lesions have also been reported in acanthosis nigricans generally. ScienceDirect+1ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS
Do not infer that correction of hypothyroidism alone will resolve acanthosis nigricans or hyperinsulinemia; reported cases showed persistence after thyroid correction. ScienceDirectScienceDirectAcanthosis nigricans, hypothyroidism, and insulin resistance - ScienceDirect
Treatment
Treat the underlying driver before cosmetic therapy
Improvement in plaques follows reduction of the pathogenic stimulus more reliably than lesion-only treatment.
For obesity-associated acanthosis nigricans, make weight reduction and treatment of insulin resistance the primary intervention. Weight loss can improve obesity-related disease, and control of hyperinsulinemia through dietary change may reduce lesion severity. Treat documented diabetes, dyslipidemia, hypertension, polycystic ovary syndrome, or suspected fatty-liver disease according to the relevant disease pathway. ScienceDirect+2ScienceDirectSuccessful treatment of acanthosis nigricans with etretinate - ScienceDirectScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed
When an identifiable medication is implicated, discontinue or substitute it when clinically feasible. If a defined endocrinopathy or internal malignancy is driving the lesions, direct treatment to that disorder; this approach may improve acanthosis nigricans and avoids ineffective escalation of cosmetic therapies. PubMedPubMedAcanthosis Nigricans: An Updated Review - PubMed
Use lesion-directed therapy only after addressing the driver and clarifying that evidence is largely symptomatic or cosmetic. Localized lesions may be treated with topical retinoids, vitamin D analogs, chemical peels, or other keratolytics; systemic oral retinoids have been considered for extensive, generalized, or topical-treatment–unresponsive disease. Laser therapy, dermabrasion, and surgical removal are less common options. PubMedPubMedAcanthosis Nigricans: An Updated Review - PubMed
Metformin has been reported to improve insulin resistance and acanthosis nigricans after treatment for at least 6 months, but the reviewed material does not establish a lesion-specific dose or make it a substitute for indication-based metabolic treatment. Wolters Kluwer+1Wolters KluwerAn approach to acanthosis nigricans : Indian Dermatology Online JournalPubMedAn approach to acanthosis nigricans - PMC
Tazarotene has been reported as symptomatic treatment in juvenile familial obesity-associated acanthosis nigricans; select topical therapy for cosmetic goals, not to exclude or treat systemic disease. WileyWileyAcanthosis nigricans: A review - Journal of Cosmetic Dermatology
Reassess lesion trajectory alongside body weight and the identified metabolic or systemic driver; continued rapid progression should reopen evaluation for an alternative cause. ScienceDirect+1ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed
Diagnostic limits
Use biopsy selectively and refer for discordant disease
Histology may support the diagnosis but does not replace etiologic assessment.
Clinical diagnosis is usually sufficient when the morphology and metabolic context are typical. Consider dermatology evaluation and biopsy when morphology is atypical, distribution is unusual, facial pigmentation raises competing diagnoses, or a mimicker such as an acanthosis nigricans-like variant of mycosis fungoides is plausible. Patch-stage mycosis fungoides may require multiple skin biopsies. Oxford Academic+1Oxford AcademicMycosis fungoides: a review - Oxford AcademicWolters KluwerFacial acanthosis nigricans − a narrative review : Pigment International
Refer urgently to endocrinology for suspected type B insulin resistance or severe dysglycemia with disproportionate hyperinsulinemia, and coordinate expedited malignancy evaluation for rapid, generalized, mucosal, or nonobese disease. The referral question should specify the phenotype, lesion tempo, glucose pattern, insulin/C-peptide results when obtained, medication exposures, and systemic cancer symptoms. Wiley+3WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : MedicineScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed
Biopsy does not distinguish benign from malignant acanthosis nigricans reliably because malignant lesions may be clinically indistinguishable from benign lesions. PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS
For facial hyperpigmentation, reconsider facial acanthosis nigricans and competing pigmentary disorders before initiating depigmenting or keratolytic treatment. Wolters KluwerWolters KluwerFacial acanthosis nigricans − a narrative review : Pigment International
References
- [PDF] 210874Orig1s000 CLINICAL REVIEW(S) - accessdata.fda.gov — www.accessdata.fda.gov · www.accessdata.fda.gov
- Type 2 diabetes in children - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com · bestpractice.bmj.com
- Cutaneous Manifestations of Internal Malignancy — acsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
- Acanthosis nigricans: A review - Journal of Cosmetic Dermatology — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Cutaneous Manifestations of Internal Malignancy - Thiers - 2009 - CA — acsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
- ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Posters - 2017 - Australasian Journal of Dermatology — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Global hotspots and trends in Acanthosis nigricans research: A ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- A case of type B insulin resistance presenting at a district general ... — wchh.onlinelibrary.wiley.com · wchh.onlinelibrary.wiley.com
- Acanthosis nigricans, hypothyroidism, and insulin resistance - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Autoimmune Forms of Hypoglycemia : Medicine — journals.lww.com · journals.lww.com
- Acanthosis Nigricans Identifies Youth at High Risk for Metabolic Abnormalities - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Mycosis fungoides: a review - Oxford Academic — academic.oup.com · academic.oup.com
- Successful treatment of acanthosis nigricans with etretinate - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- An approach to acanthosis nigricans : Indian Dermatology Online Journal — journals.lww.com · journals.lww.com
- Acanthosis Nigricans - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Facial acanthosis nigricans − a narrative review : Pigment International — journals.lww.com · journals.lww.com
- Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children - PubMed — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- [PDF] PHC ENG GUIDE 200 - Extranet Systems — extranet.who.int · extranet.who.int
- Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus - PubMed — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Acanthosis Nigricans: An Updated Review - PubMed — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- An approach to acanthosis nigricans - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- A STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Acanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov